Zyn is seeking FDA approval to say it's less harmful than cigarettes

"The Food and Drug Administration is holding a public meeting Thursday to consider whether Philip Morris International can advertise its pouches as a less-harmful alternative for adults who currently smoke cigarettes. Government documents posted before the meeting suggest FDA regulators are leaning toward approving the company's request. But the meeting will give an outside panel of health experts a chance to weigh in and ask questions of both the company and the agency."

"Philip Morris asked the agency to approve new marketing language for Zyn, emphasizing its relative health benefits when compared with cigarettes. Specifically, the company wants to say that using Zyn reduces the risk of mouth cancer, heart disease, lung cancer, stroke and other smoking-related diseases. Adding that language to Zyn marketing and promotional materials would further cement the brand in the United States, where it dominates sales of nicotine pouches."

FDA is holding a public meeting to consider Philip Morris International's request to advertise Zyn as a less-harmful alternative for adults who smoke. Government documents suggest regulators are leaning toward approving the request, while the meeting will let an outside panel of health experts ask questions of both the company and the agency. Zyn contains nicotine powder and comes in 10 flavors. Philip Morris seeks permission to claim Zyn reduces risk of mouth cancer, heart disease, lung cancer, stroke and other smoking-related diseases. FDA previously authorized Zyn to remain on the market after finding company data showed the pouches are less harmful than cigarettes.

Read at www.mercurynews.com